(2,4,5-trichlorophenoxy)acetic acid decreases expression ISO Ogn (Mus musculus) 6480464 2 more ... CTD PMID:18579281 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of OGN mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO Ogn (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGN mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO Ogn (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of OGN mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO Ogn (Mus musculus) 6480464 Estradiol results in increased expression of OGN mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO OGN (Homo sapiens) 6480464 Estradiol results in increased expression of OGN mRNA CTD PMID:25878060 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ogn (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGN mRNA and Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 and PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of OGN mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ogn (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of OGN mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OGN mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO OGN (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of OGN mRNA CTD PMID:30203000 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ogn (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of OGN mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ogn (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of OGN mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-tribromophenol decreases expression ISO OGN (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,4-diaminotoluene decreases expression ISO Ogn (Mus musculus) 6480464 2 and 4-diaminotoluene results in decreased expression of OGN mRNA CTD PMID:20713471 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO OGN (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of OGN mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO OGN (Homo sapiens) 6480464 Lactic Acid results in increased expression of OGN mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Ogn (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of OGN mRNA CTD PMID:25172293 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Ogn (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA and Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO OGN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO Ogn (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of OGN mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO Ogn (Mus musculus) 6480464 bisphenol S results in increased expression of OGN mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of OGN mRNA CTD PMID:24780913 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:19480007 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of OGN mRNA CTD PMID:28959563 aldrin decreases expression ISO Ogn (Mus musculus) 6480464 Aldrin results in decreased expression of OGN mRNA CTD PMID:18579281 antirheumatic drug increases expression ISO OGN (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of OGN mRNA CTD PMID:24449571 arsenous acid decreases expression ISO OGN (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of OGN mRNA CTD PMID:26705709 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of OGN mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO Ogn (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of OGN mRNA CTD PMID:15034205 benzo[a]pyrene increases expression ISO Ogn (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of OGN mRNA CTD PMID:22228805 bisphenol A decreases expression ISO Ogn (Mus musculus) 6480464 bisphenol A results in decreased expression of OGN mRNA CTD PMID:20739668 bisphenol A increases expression ISO Ogn (Mus musculus) 6480464 bisphenol A results in increased expression of OGN mRNA CTD PMID:30951980 more ... bisphenol A multiple interactions ISO OGN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of OGN mRNA CTD PMID:25181051 bisphenol F increases expression ISO Ogn (Mus musculus) 6480464 bisphenol F results in increased expression of OGN mRNA CTD PMID:30951980 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of OGN mRNA CTD PMID:25993096 carbon nanotube decreases expression ISO Ogn (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO OGN (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to OGN gene] CTD PMID:28238834 cisplatin multiple interactions ISO OGN (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of OGN mRNA CTD PMID:20705681 cobalt atom decreases expression ISO Ogn (Mus musculus) 6480464 Cobalt results in decreased expression of OGN mRNA CTD PMID:34468815 copper(II) sulfate decreases expression ISO Ogn (Mus musculus) 6480464 Copper Sulfate results in decreased expression of OGN mRNA CTD PMID:18579281 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of OGN mRNA CTD PMID:18480146 crocidolite asbestos decreases expression ISO Ogn (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of OGN mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of OGN mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO OGN (Homo sapiens) 6480464 Cyclosporine results in decreased expression of OGN mRNA CTD PMID:33631201 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of OGN mRNA CTD PMID:23914054 dexamethasone multiple interactions ISO Ogn (Mus musculus) 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA and Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] CTD PMID:16054899 dexamethasone multiple interactions ISO OGN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO OGN (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of OGN mRNA CTD PMID:26705709 diazinon increases expression EXP 6480464 Diazinon results in increased expression of OGN mRNA CTD PMID:29108742 dibutyl phthalate increases expression ISO Ogn (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of OGN mRNA CTD PMID:21266533 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of OGN mRNA CTD PMID:37567419 dioxygen multiple interactions ISO Ogn (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OGN mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OGN mRNA CTD PMID:33729688 diuron decreases expression EXP 6480464 Diuron results in decreased expression of OGN mRNA CTD PMID:21551480 and PMID:25152437 doxorubicin decreases expression ISO OGN (Homo sapiens) 6480464 Doxorubicin results in decreased expression of OGN mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of OGN mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO Ogn (Mus musculus) 6480464 epoxiconazole results in decreased expression of OGN mRNA CTD PMID:35436446 furan increases expression EXP 6480464 furan results in increased expression of OGN mRNA CTD PMID:27387713 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of OGN mRNA CTD PMID:33387578 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of OGN mRNA CTD PMID:24915197 glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of OGN mRNA CTD PMID:26302742 graphene oxide decreases expression ISO Ogn (Mus musculus) 6480464 graphene oxide results in decreased expression of OGN mRNA CTD PMID:33227293 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of OGN mRNA CTD PMID:21396975 indometacin multiple interactions ISO OGN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OGN mRNA CTD PMID:28628672 lipopolysaccharide multiple interactions ISO OGN (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 methotrexate decreases expression ISO OGN (Homo sapiens) 6480464 Methotrexate results in decreased expression of OGN mRNA CTD PMID:17400583 N-nitrosodiethylamine increases expression ISO Ogn (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of OGN mRNA CTD PMID:24535843 nickel atom decreases expression ISO OGN (Homo sapiens) 6480464 Nickel results in decreased expression of OGN mRNA CTD PMID:25583101 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of OGN mRNA CTD PMID:23665939 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of OGN mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of OGN mRNA CTD PMID:25729387 ozone decreases expression ISO Ogn (Mus musculus) 6480464 Ozone results in decreased expression of OGN mRNA CTD PMID:12763052 ozone multiple interactions ISO Ogn (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of OGN mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of OGN mRNA CTD PMID:34911549 paclitaxel multiple interactions ISO OGN (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of OGN mRNA CTD PMID:20705681 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of OGN mRNA CTD PMID:33387578 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of OGN mRNA CTD PMID:32680482 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of OGN mRNA CTD PMID:18158353 potassium dichromate increases expression ISO Ogn (Mus musculus) 6480464 Potassium Dichromate results in increased expression of OGN mRNA CTD PMID:23608068 purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of OGN mRNA CTD PMID:23358152 rac-lactic acid increases expression ISO OGN (Homo sapiens) 6480464 Lactic Acid results in increased expression of OGN mRNA CTD PMID:30851411 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of OGN mRNA CTD PMID:27900601 and PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO OGN (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO OGN (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of OGN mRNA CTD PMID:35811015 serpentine asbestos decreases expression ISO Ogn (Mus musculus) 6480464 Asbestos and Serpentine results in decreased expression of OGN mRNA CTD PMID:16251409 silver atom decreases expression ISO Ogn (Mus musculus) 6480464 Silver results in decreased expression of OGN mRNA CTD PMID:27131904 silver(0) decreases expression ISO Ogn (Mus musculus) 6480464 Silver results in decreased expression of OGN mRNA CTD PMID:27131904 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of OGN mRNA CTD PMID:21865292 sodium arsenite increases expression ISO OGN (Homo sapiens) 6480464 sodium arsenite results in increased expression of OGN mRNA CTD PMID:17879257 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of OGN mRNA and sodium arsenite results in decreased expression of OGN protein CTD PMID:19072884 and PMID:29459688 sodium arsenite increases expression ISO Ogn (Mus musculus) 6480464 sodium arsenite results in increased expression of OGN mRNA CTD PMID:18812580 sodium fluoride decreases expression ISO Ogn (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of OGN mRNA CTD PMID:27862939 sulforaphane decreases expression ISO Ogn (Mus musculus) 6480464 sulforaphane results in decreased expression of OGN mRNA CTD PMID:30529165 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of OGN mRNA CTD PMID:21865292 tacrolimus hydrate increases expression ISO Ogn (Mus musculus) 6480464 Tacrolimus results in increased expression of OGN mRNA CTD PMID:29362864 tadalafil increases expression ISO Ogn (Mus musculus) 6480464 Tadalafil results in increased expression of OGN mRNA CTD PMID:32513693 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of OGN mRNA CTD PMID:16239168 tetrachloromethane affects expression ISO Ogn (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of OGN mRNA CTD PMID:17484886 titanium dioxide decreases expression ISO Ogn (Mus musculus) 6480464 titanium dioxide results in decreased expression of OGN mRNA CTD PMID:23557971 and PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of OGN mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of OGN mRNA CTD PMID:25729387 triclosan increases expression ISO OGN (Homo sapiens) 6480464 Triclosan results in increased expression of OGN mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO Ogn (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of OGN mRNA CTD PMID:19042947 troglitazone increases expression ISO Ogn (Mus musculus) 6480464 troglitazone results in increased expression of OGN mRNA CTD PMID:28973697 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of OGN mRNA CTD PMID:24136188 valproic acid increases expression ISO Ogn (Mus musculus) 6480464 Valproic Acid results in increased expression of OGN mRNA CTD PMID:24896083 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of OGN mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of OGN mRNA CTD PMID:20566332